Cargando…
Refining the Treatment of Pancreatic Cancer From Big Data to Improved Individual Survival
Pancreatic cancer is one of the most lethal cancers worldwide, most notably in Europe and North America. Great strides have been made in combining the most effective conventional therapies to improve survival at least in the short and medium term. The start of treatment can only be made once a diagn...
Autores principales: | Bailey, Peter, Zhou, Xu, An, Jingyu, Peccerella, Teresa, Hu, Kai, Springfeld, Christoph, Büchler, Markus, Neoptolemos, John P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165547/ https://www.ncbi.nlm.nih.gov/pubmed/37168490 http://dx.doi.org/10.1093/function/zqad011 |
Ejemplares similares
-
Clinical Impact of Molecular Subtyping of Pancreatic Cancer
por: Zhou, Xu, et al.
Publicado: (2021) -
Corrigendum: Clinical impact of molecular subtyping of pancreatic cancer
por: Zhou, Xu, et al.
Publicado: (2023) -
Using big data for evaluating development outcomes: A systematic map
por: Rathinam, Francis, et al.
Publicado: (2021) -
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC
por: Zhou, Xu, et al.
Publicado: (2023) -
Pancreatitis and pancreatic cancer: A case of the chicken or the egg
por: Umans, Devica S, et al.
Publicado: (2021)